AGBL2 and synovitis: In CCP2+ at-risk individuals with MSK symptoms but without clinical synovitis, the majority of progressors go through a stage of US subclinical joint inflammation prior to the development of inflammatory arthritis, thus representing a distinct and important stage of the ‘RA continuum'.